COVID-19 Vaccine Frequently Asked Questions
The City of Cambridge and the Cambridge Public Health Department recognize that there are many questions regarding the COVID-19 vaccine, including safety of the vaccines; trust in government and pharmaceutical companies who developed the vaccines; potential side effects; who should and should not receive the vaccine; and where vaccines will be administered. CPHD and the City will continue to update residents and those who work in Cambridge as more information becomes available.
Daily Log 5.24.2023
An overview of the Cambridge Police Department's daily calls for service for May 24, 2023
COVID-19 Vaccine Frequently Asked Questions (as of December 23, 2020)
The City of Cambridge and the Cambridge Public Health Department recognize that there are many questions regarding the COVID-19 vaccine, including safety of the vaccines; trust in government and pharmaceutical companies who developed the vaccines; potential side effects; who should and should not receive the vaccine; and where vaccines will be administered. CPHD and the City will continue to update residents and those who work in Cambridge as more information becomes available.
CHRC Gender Identity the Law Training
Effective Oct. 1, 2016, the Commonwealth of Massachusetts prohibits discrimination based on gender identity in places of Public Accommodation. A place of public accommodation as defined in M.G.L.c. 272 92A includes any place open to and serving the public. This training details how businesses can comply with the state’s gender identity non-discrimination law in places of public accommodation. In addition, the training covers best practices for maintaining inclusive environments regardless of one’s gender identity.
CDC Statement on ACIP Booster Recommendations
CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in certain populations and also recommended a booster dose for those in high risk occupational and institutional settings. The Food and Drug Administration’s (FDA) authorization and CDC’s guidance for use are important steps forward as we work to stay ahead of the virus and keep Americans safe.